Overview
Status
Active
Registry date
2001-03-29
Share capital
25,500.00 PLN
Activity description
Sanprobi tests probiotic quality and explores new uses for probiotic bacteria. It packages them in blisters and capsules under sterile conditions, stores them with controlled temperature and humidity, and supplies them exclusively to pharmacies.
Registered address
Kurza Stopka 5/C, 70-535 Szczecin, Poland
Website
Email
Phone
Electronic delivery address
AE:PL-63925-70619-BCSCG-18
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 89 days late).
- 202503/07/2026
- 202411/07/2025
- 202325/04/2024
- 202206/07/2023
- 202112/10/2022
- 202011/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 75.47kMedianUSD 66.63kAverageUSD 1.19m
Net profit
This companyUSD 10.31kMedianUSD 1.80kAverageUSD 66.86k
Operating costs
This companyUSD 13.55kMedianUSD 50.36kAverageUSD 1.01m
Assets
This companyUSD 238.54kMedianUSD 69.63kAverageUSD 2.60m
Industry
Authorized Representatives
Agnieszka Teresa Wojtkun – Attorney-in-fact (sole)
Igor Piotr Łoniewski – President of the Management Board
Robert Tadeusz Kornecki – Attorney-in-fact (sole)
Wojciech Maciej Marlicz – Vice President of the Management Board
Manner of representation
Independent representation (one-person).
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Robert Tadeusz Korneckiage 62 | 17 | $2,296.06 | 33.3333% |
Igor Piotr Łoniewski | 17 | $2,296.06 | 33.3333% |
Wojciech Maciej Marliczage 54 | 17 | $2,296.06 | 33.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
14 1240 3826 1111 0010 5537 6081
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $770$770 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,533$1,533 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $770$770 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bionatursp. z o.o. | $150,929.18 | bionatur.pl | ||
| Over Groupsp. z o.o. | $131,106.53 | over-group.com | ||
| BIO Balance Dystrybucjasp. z o.o. | $80,536.48 | biobalance.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-12-28 | Share capital increase (25,000.00 PLN → 25,500.00 PLN) | |
| 2014-12-16 | Name change ("i.p.c International Pharmaceutical Consulting" → Sanprobi Spółka Z Ograniczoną Odpowiedzialnoscią) | |
| 2004-02-06 | Share capital increase (5,000.00 PLN → 25,000.00 PLN) | |
| 2001-03-29 | Entered in the register |
FAQ
Last updated: 2026-07-06